Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Large-scale testing (Phase 3)Looking for participantsNCT06320067
What this trial is testing

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University College, London 3,360
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01342172
What this trial is testing

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasms
Icahn School of Medicine at Mount Sinai 9
Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Early research (Phase 1)Study completedNCT02826772
What this trial is testing

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Suzhou Kintor Pharmaceutical Inc, 40
Not applicableUnknownNCT02803619
What this trial is testing

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal Metastasis
Peking Union Medical College Hospital 60
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Not applicableLooking for participantsNCT06197776
What this trial is testing

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Who this might be right for
Multi-omics TechniqueNasopharyngeal CarcinomaRecurrent and Metastatic Nasopharyngeal Carcinoma+1 more
Sun Yat-sen University 50
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,000
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Testing effectiveness (Phase 2)Ended earlyNCT03645876
What this trial is testing

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Large-scale testing (Phase 3)Study completedNCT03802591
What this trial is testing

CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
CStone Pharmaceuticals 479
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05859217
What this trial is testing

Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

Who this might be right for
Lung CancerNSCLC Stage IVMetastatic NSCLC - Non-Small Cell Lung Cancer+1 more
Jun Zhang, MD, PhD 40
Large-scale testing (Phase 3)Study completedNCT03802240
What this trial is testing

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 492
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Testing effectiveness (Phase 2)Study completedNCT01117428
What this trial is testing

Sym004 in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Colorectal Cancer
Symphogen A/S 111
Next Page